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Abstract 1 
 2 
Aims. This review examined studies of executive functioning in abstinent ecstasy 3 
(MDMA) users on tasks which had been empirically mapped onto updating, 4 
shifting, inhibition and accessing long term memory executive processes. Studies 5 
of some aspects of visuospatial memory performance were also included 6 
because of the investment of executive resources in such tasks. 7 
 8 
Methods. Thirty three studies were identified for the review following searches of 9 
the Psychinfo and Medline databases. Inclusion criteria included the reporting of 10 
new empirical findings from participants drug free at the time of testing, in peer 11 
reviewed journals in the English language.  12 
 13 
Results. Evidence for ecstasy related performance deficits was strongest for the 14 
updating of verbal material, and for visuospatial memory tasks requiring 15 
additional processing beyond storage and retrieval. Such processing suggested 16 
that overall level of executive demand was an important consideration. Executive 17 
shifting showed little evidence of ecstasy related impairment, whilst examination 18 
of inhibition and long-term memory access presented an unclear picture.  19 
 20 
Conclusions. All but one of the studies had a cross-sectional design. Although 21 
this is a potential weakness with regard to confounds, the necessity of such 22 
designs was acknowledged. Studies were generally aware of the need to control 23 
for potential confounds, especially the effects of other drugs, through a mixture of 24 
group designs and statistical techniques. It was recommended that future studies 25 
of executive functioning in ecstasy users should detail the relationship of the 26 
tasks and dependent variables reported to specific executive processes, and 27 
consider the level of executive demand imposed by such tasks. 28 
29 
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Introduction 30 
 31 
This review examined research reporting the presence or absence of deficits 32 
associated with the use of the drug ‘ecstasy’ (MDMA) in executive working 33 
memory processes in abstinent users. This is an important area to review for a 34 
number of reasons. United Kingdom evidence indicates that ecstasy ranks fourth 35 
in the list of Class A illegal drugs with regard to having been consumed at some 36 
time, with over 2.3 million people reporting some exposure to it [1]. Furthermore, 37 
as previous reviews have reported, ecstasy related performance deficits do not 38 
appear on all cognitive tasks or in all published studies [2, 3], so that it is 39 
important to monitor the patterns of  findings in this field in order to establish a 40 
coherent understanding of such effects. One particularly important issue 41 
regarding ecstasy related performance deficits concerns the difficulties 42 
associated with eliminating the effects of potential confounds from reported 43 
results, most notably the possibility of effects arising from the use of other drugs 44 
[4]. Other potential confounds include differences in age and IQ between ecstasy 45 
users and controls. Attempts to control for such confounds across studies also 46 
require some examination in order for the quality of evidence concerning ecstasy 47 
related deficits to be established. The term ‘abstinent’ in this review indicates that 48 
ecstasy users were not under the influence of the drug at the time they were 49 
tested, even though use of the drug may have been relatively recent. 50 
 51 
The construct of working memory combines short-term storage processes with 52 
other aspects of cognitive activity, such as learning and reasoning [5]. Models of 53 
working memory commonly emphasise both the storage and retrieval of task 54 
related material, and additional processing relevant to that task [6]. This 55 
additional processing is seen as part of the executive functioning of working 56 
memory, implying a directive role in the employment of cognitive resources to 57 
manage the demands facing a person. Working memory, therefore, involves both 58 
executive and non-executive processes, with the latter concerned with storage. 59 
Specific executive processes of working memory have been identified by logical 60 
deduction (e.g. mediating access to long-term memory [7]), and empirically by 61 
latent variable analysis [8, 9], and exploratory factor analysis [10] on data from 62 
tasks thought likely to utilise executive processes. In particular, latent variable 63 
analysis of visuospatial performance data demonstrated that any distinction 64 
between tasks requiring only storage and retrieval, and tasks requiring additional 65 
goal orientated processing could be discarded, as both types of task drew upon 66 
executive capacity [9]. Table 1 summarises details of other executive processes 67 
identified empirically and the tasks associated with them.  68 
 69 
Insert Table 1 about here.  70 
 71 
This review examined ecstasy related effects concerning the four executive 72 
processes shown in Table 1 by examining studies using the tasks listed with an 73 
empirically demonstrated link to them, or close variants of these tasks. In order to 74 
maximise understanding of reported ecstasy related effects, or of their absence, 75 
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particular attention was paid to the dependent measures reported, and 76 
researchers’ attempts to control potential confounds. Visuospatial memory is a 77 
broad area of functioning, and it is apparent that any form of visual stimulus is 78 
likely to have a spatial dimension to it. In order to sharpen the focus of this review 79 
it was decided to focus upon visuospatial findings from tasks requiring recall or 80 
recognition targeted specifically upon the spatial distribution of individual 81 
elements of a display, rather than the recall, reproduction, or recognition of 82 
overall patterns or figures.  83 
 84 
Method 85 
 86 
Identification of Studies 87 
 88 
Each task listed in Table 1 was paired with the terms ‘ecstasy’ and ‘MDMA’, 89 
respectively, to form forty different search terms in the Psychinfo and Medline 90 
databases. Additionally, the terms ‘visuospatial’, ‘word fluency’ and ‘verbal 91 
fluency’ were also paired with ‘ecstasy’ and ‘MDMA’, respectively, to form six 92 
more search terms. Searches were carried out between July and September 93 
2008, and no date limitations on publication were specified. The broad term 94 
‘visuospatial’ was chosen in order to include as many studies as possible at this 95 
stage which had included coverage of this aspect of functioning in their 96 
investigation. The terms ‘word fluency’ and ‘verbal fluency’ were included so as to 97 
identify studies using close variants of the Chicago word fluency task identified in 98 
Table 1 as being associated with access to long-term memory (LTM). As all such 99 
fluency tasks require participants to produce as many words as possible within a 100 
given time starting with a designated letter, it was decided that the review would 101 
be enhanced by including all studies sharing this procedural similarity. The only 102 
task subsequently to be included in this way is referred to in this review as the 103 
FAS task (sometimes referred to elsewhere as the Controlled Oral Word 104 
Association Task or COWAT), which employs oral word production in contrast to 105 
the written production required by the Chicago word fluency task. 106 
 107 
The initial searches produced references to 59 studies which were then 108 
examined with regard to the inclusion and exclusion criteria for this review. The 109 
fundamental inclusion criteria were that studies had to report new empirical 110 
findings, or attempted replications, concerning the relationship between ecstasy 111 
use and performance on either a task listed in Table 1, or a test of visuospatial 112 
memory which required the recall or recognition of the spatial distribution of 113 
individual elements of a display, rather than the recall, reproduction, or 114 
recognition of patterns or figures. Studies also had to be published in peer 115 
reviewed journals. Review articles, conference abstracts, and theses abstracts 116 
were, therefore, excluded. By implication of these  inclusion criteria, studies were 117 
reporting findings concerning human rather than animal participants. Additionally, 118 
for inclusion in the review it was necessary for studies to have employed some 119 
criterion regarding a minimum period since ecstasy had last been used, so that 120 
studies of task performance under the drug’s intoxication were excluded. Studies 121 
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were excluded if they were not published in the English language, or if the 122 
findings concerning the relevant tasks were reported in a composite form (i.e. as 123 
a combined measure with other tasks). Application of the inclusion and exclusion 124 
criteria yielded a total of 33 studies for inclusion in this review.  125 
 126 
Data extraction 127 
 128 
The national origin of each of the 33 included studies was recorded with regard to 129 
where data collection had been conducted. The label ‘community sample’ was 130 
applied where recruitment had employed advertisements or outreach work at 131 
social events. Where recruitment had focussed primarily upon students, but with 132 
additional snowball sampling which might have brought in non-students, these 133 
studies were recorded as having a ‘predominantly student sample’, as none of 134 
them provided a precise occupational breakdown for the sample. The status of 135 
control groups was recorded according to whether they had been defined by 136 
matching the ecstasy user group(s) on the use of more than one illicit drug 137 
(recorded as ‘polydrug controls’); defined as matching ecstasy users primarily on 138 
the use of cannabis, with or without additional matching on other drug use 139 
(recorded as ‘cannabis using controls’); or defined as nonusers of illicit drugs 140 
(labelled as ‘drug naïve controls’). On occasions were researchers had allowed 141 
minor infringements of group selection criteria, such as allowing participants with 142 
very small levels of cannabis use into an otherwise drug naïve control group, 143 
note of this was included in the coding (e.g. near drug naïve controls). 144 
Descriptors such as ‘light’ or ‘moderate’ in relation to ecstasy user groups were 145 
applied in the ways used by the authors of the studies in question. 146 
 147 
Measures of time since last ecstasy use and estimates of lifetime use were 148 
recorded in the form they were reported, with regards to means, standard 149 
deviations, and ranges. Where statistics on time since last ecstasy use were not 150 
reported, the study’s minimal time since last use for inclusion in the sample was 151 
recorded. Where estimates of lifetime use were not reported an implied estimate 152 
was recorded based on the data available. For each study the executive task(s) 153 
used from those listed in Table 1, or which tested visuospatial memory in a way 154 
matching the inclusion criteria for this review, were recorded.  155 
 156 
Details of each study’s attempts to control potential confounds were recorded, 157 
with particular note being made of matching group designs (see above) and the 158 
use of statistical techniques, respectively. The findings of each study were 159 
recorded with regard to the particular dependent variables generated by tasks 160 
upon which ecstasy related performance deficits were reported as either present 161 
or absent.  162 
 163 
Results 164 
 165 
 Overview 166 
 167 
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Table 2 summarises the data extracted from the 33 studies identified for inclusion 168 
in this review. Given that ecstasy use is the focus of this review, and to avoid 169 
verbal redundancy, the term ‘users’ is used in Table 2 to identify participant 170 
groups who have used this drug. It was decided that the stated objectives for this 171 
review, with regard to examining ecstasy related performance deficits in relation 172 
to dependent measures reported and controls employed, would not be enhanced 173 
by the application of statistical analysis at this point. Furthermore, the review was 174 
concerned with differences in the appearance of such deficits across different 175 
areas of executive functioning, rather than the establishment of an overall mean 176 
effect size. Further details of results are presented below with regard to 177 
previously identified areas of executive functioning [8, 9, 10].  178 
 179 
Insert Table 2 about here 180 
 181 
Ecstasy and executive updating  182 
 183 
Nine studies listed in Table 2 report findings concerning the performance of 184 
ecstasy users on tasks shown to load upon executive updating [11 - 19]. All but 185 
one of these have been produced by some combination of the current authors, 186 
with some additional colleagues contributing. Performance deficits in ecstasy 187 
users on the computation span task were reported in seven of these studies [11 - 188 
16, 19], with 27 of the 44 ecstasy users in Fisk et al. [13] also being included in 189 
the user group of Montgomery et al. [14]. The computation span task requires 190 
participants to perform a series of simple arithmetic calculations whilst 191 
remembering the second digit from each calculation for subsequent serial recall. 192 
The item for storage and retrieval is, therefore, verbal in nature. Of the five 193 
studies where span scores are reported the largest mean difference is 2.48 span 194 
items between former users who had abstained from ecstasy for at least 6 195 
months and polydrug controls (scores of 2.75 and 5.23, respectively [19]). The 196 
remaining two studies reported percentage scores as a dependent variable, 197 
based upon the difference between computation and digit span scores [11, 15]. 198 
 199 
Where Analysis of Covariance (ANCOVA) was used to control for cannabis, 200 
alcohol, and nicotine use [12, 13, 15], ecstasy related performance deficits 201 
remained statistically significant, as they also did for amphetamine and cocaine 202 
use [13]. As with all ANCOVA results concerning other drug use in this section on 203 
updating, the validity of the obtained result was examined by testing the 204 
homogeneity of regression with regard to the interaction of the independent 205 
variable (participant group) and the covariate (e.g. cannabis use: see Discussion 206 
and also [20]). Where ANCOVA was not possible due to too few users of a 207 
particular drug, or where homogeneity of regression was not achieved, either 208 
initial ANOVAs were repeated with the exclusion of participants with exposure to 209 
the covariate drug in question, or bivariate correlations between computation 210 
span performance and the covariate were reported. Performance deficits in 211 
ecstasy users remained significant with the removal of participants with exposure 212 
to amphetamine, cocaine, or poppers (amyl nitrate) [12]. However, the 213 
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correlational strategy did produce a slightly confused picture with task 214 
performance showing a significant negative relationship with ecstasy but not 215 
cannabis consumption [15], with cannabis but not ecstasy consumption [14], and 216 
with the consumption of both drugs [11].  217 
 218 
In addition to the use of other drugs, ANCOVA has also been used to control for 219 
other potential confounds which could be responsible for ecstasy users’ 220 
performance deficits on computation span. The nocturnal lifestyle associated with 221 
the drug’s use has led to suggestions that cognitive deficits generally which have 222 
been associated with its use may actually be the result of sleep disturbance [21]. 223 
However, ecstasy related computation span deficits remained significant when 224 
sleep quality measures were controlled by ANCOVA [11], although homogeneity 225 
of regression results were not reported.  It has also been suggested that ecstasy 226 
users may develop an increased vulnerability to age related cognitive deficits due 227 
to ecstasy exacerbating the normal decline of serotonergic functioning with age 228 
[22]. As age related cognitive deficits are characterised at a psychological level  229 
by a decline in information processing speed, Wareing et al. [16] controlled this 230 
variable with ANCOVA and found that ecstasy related computation span deficits 231 
remained, with homogeneity of regression being achieved. This suggests that the 232 
psychological mechanism underlying ecstasy related cognitive deficits is different 233 
from that underlying age related deficits. It would be difficult to map such a 234 
difference in psychological mechanisms onto neurobiological processes as 235 
changes in serotonergic functioning have been reported in numerous brain 236 
regions in relation to both ecstasy use [23] and ageing [24, 25].   237 
  238 
Ecstasy users have been reported to perform worse than controls on the 239 
consonant updating task [11, 14, 15, 17]. This task requires participants to recall 240 
a given number of the most recent consonants in their correct order from 241 
sequences of varying lengths. Performance may be scored in relation to correct 242 
recall, either across all serial positions or for respective serial positions.  243 
Correlational analysis has once again presented a slightly confusing picture with 244 
performance on this task being negatively related to the consumption of cocaine 245 
but not ecstasy and cannabis [11], to the consumption of ecstasy but not 246 
cannabis or cocaine [15, 17], and unrelated to the consumption of ecstasy, 247 
cannabis, cocaine, and amphetamine [14]. Performance deficits in ecstasy users 248 
have been reported with ANCOVA controlling for age, and the consumption of 249 
alcohol, tobacco, and cannabis, with homogeneity of regression being achieved 250 
[15]. Given that working memory includes both passive non-executive storage 251 
processes as well as active executive processes [6], one study [17] explored the 252 
contribution of serial position and passive memory span to the performance 253 
deficits observed in ecstasy users on this task. Users actually had significantly 254 
higher letter span scores than polydrug controls, indicating that users’ depressed 255 
performance on the updating task did not arise from passive storage deficits. 256 
 257 
Regarding other updating tasks, an initial performance deficit  in ecstasy users in 258 
reading span became nonsignificant when cannabis consumption was controlled 259 
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by ANCOVA [12], whilst ecstasy users showed no deficit in performance on the 260 
keep track task [18] where cannabis use was controlled by a matched group 261 
design. The reading span task presents participants with a series of sentences, 262 
requiring them to answer a question about each sentence, respectively, whilst 263 
remembering the last word of each sentence for subsequent serial recall. The 264 
keep track task requires participants to recall the last word presented from each 265 
of n categories, where presentation order has been randomised. 266 
 267 
In summary, the studies cited report fairly robust effects with regard to 268 
performance deficits for ecstasy users compared to controls on the computation 269 
span and consonant updating tasks. Furthermore, the presence of computation 270 
span deficits in users who had been abstinent for at least 6 months after 271 
consuming an average in excess of 400 tablets may be considered noteworthy 272 
[19: see also Table 2). However, correlational data between performance on both 273 
tasks and the use of ecstasy and other drugs did not present the entirely 274 
consistent picture which would be expected if such deficits were entirely linked to 275 
ecstasy use. Furthermore, controlling for cannabis use has led to no ecstasy 276 
related deficits being reported for two other updating tasks. Such inconsistent 277 
results across tasks could be seen to raise questions of the specific brain areas 278 
and non-executive processes recruited by respective tasks. However, it is also 279 
important to consider the details of task administration and measurement 280 
employed. For example, in their latent variable study Miyake et al. [8] employed 281 
six categories in the keep track task whilst Dafters [18] employed only four with 282 
ecstasy users and controls. This presumably reduced the demand on the 283 
executive resources of participants. Further investigation here could vary this 284 
level of demand. With regard to reading span [12], further investigation could, for 285 
example, examine the correct number of serial positions recalled as a dependent 286 
variable potentially more sensitive to executive workload than span scores.  287 
 288 
Ecstasy and executive shifting 289 
 290 
Six studies listed in Table 2 report results concerning the performance of ecstasy 291 
users on tasks reported in Table 1 to load upon executive shifting [14, 26 – 30]. 292 
No ecstasy related differences were reported on either the plus/minus task or the 293 
number/letter task [14]. The most commonly reported shifting task with ecstasy 294 
users is the Wisconsin card sorting task (WCST) which requires participants to 295 
sort cards according to one of three criteria, colour, shape or number. The 296 
criterion for sorting is changed without warning when a designated number of 297 
cards have been correctly sorted [8, 10]. The number of cards presented can be 298 
varied, as can the number of correctly sorted cards required for a criterion 299 
change. However, these details are not reported in all studies with ecstasy users 300 
and studies also differ regarding the dependent variables they examine.  301 
 302 
Where no ecstasy related WCST performance deficits were reported other drug 303 
use was controlled through the use of one or more matched control group [26 - 304 
29]. In one study results on the dependent variables analysed were not reported 305 
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in detail [26]. Where dependent variables were reported in detail no ecstasy 306 
related deficits emerged on the number of categories completed, the number or 307 
percentage of perseverative errors (i.e. failing to change the sorting principle 308 
when the criterion had changed), the number or percentage of nonperseverative 309 
errors [27, 29], as well as the number of trials taken to complete the first 310 
category, and failure to maintain set [27]. In the remaining study [28] polydrug 311 
using controls actually performed significantly worse than both current and former 312 
ecstasy users on perseverative errors, whilst the other dependent variables 313 
generated by this task which yielded no significant differences are not detailed. 314 
As these studies had presumed abstinence from ecstasy and other illicit drugs for 315 
at least 6 days prior to testing, no contradiction is posed by deficits reported in 316 
ecstasy users who had consumed the drug 10 to 15 hours prior to testing [25: not 317 
included in this review].  318 
 319 
The only study to report ecstasy related deficits on the WCST in abstinent users 320 
[30] recruited participants from a region of the United States where cultural and 321 
religious norms minimised exposure to other drugs including alcohol. Only a 322 
comparison between heavy users (n = 11, with more than 50 episodes of use) 323 
and nonusers yielded a difference on total categories completed, with only simple 324 
significance being achieved.  325 
 326 
Although the Stroop task has been shown to be related to executive inhibition 327 
rather than shifting (see Table 1), Dafters [18] manipulated the procedure for this 328 
task by requiring participants to switch from naming the ink colour to naming the 329 
word on certain trials. Ecstasy users showed longer reaction times than other 330 
groups when doing this, which was interpreted as showing an impaired switching 331 
or shifting process. However, such a measure has not been tested empirically 332 
with regard to its relationship to other tasks loading on this process [8, 10]. 333 
Mapping the diverse requirements of individual tasks to specific executive 334 
processes in not always straight forward (eg. random letter generation, see [10]), 335 
and this manipulation could conceivably reflect a deficit in the regulation of 336 
inhibition, rather than shifting. 337 
 338 
In summary, there is little evidence to date to suggest that ecstasy use is related 339 
to impairment of executive shifting.  340 
 341 
Ecstasy and executive inhibition 342 
 343 
Seventeen studies are identified in Table 2 as presenting results concerning 344 
tasks shown in Table 1 as loading upon executive inhibition [13 - 15, 18, 22, 26, 345 
27, 29, 32 - 40]. Eight of these report findings from the Stroop task. Conventional 346 
Stroop measures reflect differences in the time taken to name a stimulus colour 347 
when the stimulus is a conflicting colour word (such as ‘red’ written in blue ink), 348 
compared to one or more conditions where either the word and the stimulus 349 
colour match (such as ‘red’ written in red ink) or the stimulus is not a word (such 350 
as a red asterisk). No ecstasy related deficits on standard measures from this 351 
10 
 
task were reported in six studies [18, 26, 33, 35, 39, 40]. Of the other two studies, 352 
Croft et al [32] reported equivocal findings, in that an initial ANOVA showed no 353 
significant main effect for processing speed across their three groups of 354 
ecstasy/cannabis users, cannabis but not ecstasy users, and near drug naïve 355 
controls. However,  ANCOVA performed with both user groups combined, using 356 
measures of cannabis and ecstasy use as respective covariates, indicated that 357 
ecstasy use was more strongly related to performance deficits than cannabis 358 
use. Homogeneity of regression results were not reported for these analyses. 359 
Similarly equivocal were the findings from a Hong Kong sample [34] where 360 
discriminant function analysis significantly classified ecstasy users with 99% 361 
accuracy based on response times. However, after controlling for multiple 362 
comparisons, users’ task performance was not significantly worse than that of 363 
controls who appear to have been drug naïve, although precise data is not 364 
reported on their drug using history. Furthermore, estimated ecstasy 365 
consumption did not correlate with task performance. This study is rare in the 366 
literature on ecstasy related cognitive functioning as a whole, as the authors 367 
report that the 100 ecstasy users tested had taken no other illicit drugs, with 368 
regular use of alcohol and tobacco also being exclusion criteria. 369 
 370 
Whilst reporting no ecstasy related deficits on standard Stroop measures, one 371 
researcher manipulated the administration and measurement of performance on 372 
this task in order to explore ecstasy related inhibitory effects further [35]. Dafters 373 
claimed to have isolated negative priming inhibition as distinct from the conscious 374 
inhibition of a prepotent response by, for example, presenting ‘red’ in blue ink on 375 
one trial so that the response ‘red’ would be inhibited, and then making such an 376 
inhibited response the target response on the next trial. In contrast to the 377 
conventional measure, there were significant reaction time differences which 378 
were interpreted as showing reduced negative priming inhibition in ecstasy users. 379 
Whilst ANCOVA was used to control for the effects of other drug use, 380 
homogeneity of regression results were not reported. A cannabis polydrug control 381 
group was also used, but their use of cocaine and amphetamine was much less 382 
than that of the ecstasy users. 383 
 384 
The Tower of London (TOL) task is a close variant of the Tower of Hanoi (TOH) 385 
task, and since the latter has been found to load on shifting [8], results from the 386 
TOL task will be considered here. The TOL task requires participants to move 387 
coloured balls between different locations in order to achieve a goal configuration 388 
in the smallest number of moves. Three studies have reported no performance 389 
deficits amongst ecstasy users on this task compared to controls, with two of 390 
these studies comprising one publication [22]. In both of these studies no 391 
intergroup effects were found for the dependent variables of excess moves per 392 
problem, proportion of perfect solutions, and subsequent thinking time per move. 393 
In Study 2 the dependent variable of initial thinking time showed a trend 394 
approaching significance with post-hoc analyses showing that users and 395 
polydrug controls took significantly less time than drug naïve controls, whilst no 396 
effect was found on this variable in Study 1. In the third study no ecstasy related 397 
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effects were reported for the percentage correct, number of attempts required to 398 
complete each set of moves, and latency to initial response variables [38]. Whilst 399 
results for seven dependent variables are reported for these three studies, it is 400 
likely that initial thinking time [22] and latency to initial response [38] constitute 401 
the same measure. However, the relationship between proportion of perfect 402 
solutions [22] and percentage correct [38] is not so clear. It is also apparent that 403 
subsequent thinking time per move [22] and solution times [27: discussed below) 404 
are not the same variable. Overall, there does appear to be a need in this field of 405 
research for some standardisation of reporting the results from tasks generating 406 
a range of dependent variables in order to facilitate the comparison of findings.  407 
 408 
By contrast to these nonsignificant findings, ecstasy users reporting problems 409 
with their use of the drug have shown significantly longer solution times 410 
compared to controls with some level of polydrug use, whilst users not reporting 411 
problems have shown significantly longer initial planning times than both this 412 
control group and users with problems [27]. However, no performance deficits 413 
were reported for the number of errors or number of trials completed. 414 
Nonparametric ANOVA found no intergroup differences in other drug use. Finally, 415 
although de Sola Llopis et al [36] report no intergroup differences for the total 416 
number of movements or for initiation time, estimated lifetime ecstasy 417 
consumption was significantly correlated with total number of movements.  418 
 419 
Impaired performance on random letter (consonants only) generation has been 420 
reported for ecstasy users compared to controls, with regard to the number of 421 
vowel intrusions [37]. However, comparisons were not conducted on 422 
performance differences between the current users, former users, and controls 423 
on this dependent variable. Other drug use, information processing speed, 424 
health, and mood measures were controlled by ANCOVA with homogeneity of 425 
regression being reported. However, for some covariates there were no users in 426 
at least one of the participant groups, thus compromising the procedure for 427 
testing homogeneity of regression [20]. Furthermore, this specific dependent 428 
variable was not tested for its relationship to executive processes [10], and two 429 
further studies by the original research team failed to replicate group differences 430 
on any measure from this task [13, 15]. It should be noted that, in so far as it can 431 
be calculated from the data reported, the mean estimated lifetime ecstasy use in 432 
the original study [37] was in excess of 1,000 tablets, which was much more than 433 
in the subsequent studies. Whilst it remains possible that the initially reported 434 
performance deficits could be related to excessive ecstasy intake compared to 435 
subsequent studies, the small sample size of the initial study with only 10 current 436 
and former users, respectively, also places a limit on the confidence which may 437 
be placed in this finding.  438 
 439 
In summary, there seems to be little evidence for ecstasy related impairments on 440 
tasks of executive inhibition. However, the diversity of dependent variables 441 
reported does not facilitate the development of a clear appraisal of this area. The 442 
reporting of such an impairment for negative priming inhibition, but not for 443 
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conscious inhibition [35], suggests that the concept of executive inhibition itself 444 
may need to be developed further in order to provide a better picture of how 445 
research into the ways in which ecstasy use may or may not affect it may best be 446 
conducted. 447 
 448 
Ecstasy and access to long term memory (LTM) 449 
 450 
The previous discussion of random letter generation in the context of inhibition 451 
may also be applied to access to LTM, as this is the only task in Table 1 to have 452 
been found to load significantly upon two executive functions [10]. The failures to 453 
replicate original findings of ecstasy related deficits on this task [13 15], taken 454 
together with the small sample size for the original study [37], are not consistent 455 
with the ecstasy related impairment of this executive function. 456 
 457 
The Chicago word fluency task requires participants to write down as many 458 
words as possible beginning with the letter ‘S’ in 5 minutes, and to repeat this 459 
procedure with the letter ‘C’ in 4 minutes, with the added requirement that only 460 
four letter words could be produced. Task completion requires access to 461 
semantic long term memory [10]. Three studies report ecstasy related deficits on 462 
this task [11, 14, 41]. Twenty seven of the 104 ecstasy users in the sample for 463 
Montgomery et al. [11] had comprised the sample for Study 1 of the earlier 464 
publication [14], and significant negative correlations were found between 465 
performance and measures of both ecstasy and cocaine use in both studies. 466 
Ecstasy related deficits also remained when sleep quality measures were 467 
controlled by ANCOVA, although homogeneity of regression was not reported 468 
[11]. The third study employed only the ‘C’ condition of the task, and employed a 469 
matched control group with regard to cannabis but not cocaine use. However, 470 
alcohol, cannabis and cocaine were controlled through ANCOVA, but without 471 
homogeneity of regression being reported [41].  472 
 473 
Table 2 also shows that three studies [38, 42, 43] reported performance deficits 474 
in ecstasy users on a task where participants were required to produce orally (as 475 
opposed to writing) as many words as possible beginning  with the letters ‘F’, ‘A’, 476 
and ‘S’, in 1 minute respectively for each letter (referred to as the FAS task in 477 
Table 2). Other drug use was controlled for in two of these studies by a 478 
combination of t-tests, correlation and ANCOVA [38, 42], although homogeneity 479 
of regression results were not reported. The third study [43] relied on its group 480 
design to control for other drug use. However, three other studies have reported 481 
ecstasy users to show no performance deficits on this task compared to controls 482 
[30, 32, 33].  483 
 484 
In summary, the two tasks with an empirical basis for the claim that they load on 485 
access to LTM [10] point to different conclusions regarding the ecstasy related 486 
impairment of this function. As an oral variant of the Chicago word fluency task, 487 
the FAS task has produced contradictory results. It is apparent that any firm 488 
conclusion regarding the possible ecstasy related impairment of this executive 489 
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function requires further investigation. A broader range of tasks shown 490 
empirically to have some relationship to this function would also be helpful.  491 
 492 
Ecstasy and visuospatial memory 493 
 494 
Table 2 lists 18 studies reporting results on the performance of ecstasy users on 495 
visuospatial memory tasks. Table 3 summarises the findings from 11 of these 496 
studies regarding tasks where ecstasy related performance deficits, or significant 497 
relationships between ecstasy consumption and performance, were reported for 498 
at least one measure. It can be seen that two of these studies reported deficits in 499 
the updating of visuospatial material [15, 17] which may be consistent with the 500 
deficits in updating verbal material reported above. Table 4 summarises findings 501 
from 12 of the 18 studies regarding tasks which did not demonstrate these 502 
ecstasy related effects. Studies are included in both tables where different tasks 503 
produced contrasting results. 504 
 505 
Insert Tables 3 and 4 about here 506 
 507 
The majority of studies listed in Table 3 used some form of statistical control with 508 
regard to potential confounds such as IQ and other drug use. The exception to 509 
this was [39] where statistical comparisons between users and nonusers on such 510 
confounds were confined to sub-groups selected for additional SPECT 511 
examination. In six studies where ANCOVA was used homogeneity of regression 512 
results were reported in three [15, 19, 45], but not in three others [36, 38, 44]. In 513 
two studies performance deficits were reported in former users who had not used 514 
ecstasy for at least 6 months [19, 45] as well as current users. The latter of these 515 
studies also indicated that both cannabis and ecstasy could be contributing to the 516 
observed impairments. Deficits were also reported in participants described as 517 
“light users” [15] and “moderate users” [44] with respective means (and SDs) of 518 
149.69 (96.91) and 169 (252) for estimated lifetime tablet consumption.  519 
 520 
Latent variable analysis with visuospatial tasks has shown that both those tasks 521 
which require minimal additional processing beyond storage and retrieval, and 522 
those requiring significant additional processing, draw upon executive capacity 523 
[9]. It may be argued that all of the findings in Table 4 come from tasks requiring 524 
only minimal additional processing. By contrast, eight of the findings in Table 3 525 
would appear to be from tasks requiring significant additional processing, the 526 
exceptions being [27, 43, 44]. It should be noted that whilst conventional Corsi 527 
block and span measures require minimal additional processing, backwards 528 
spatial sequence and span measures do require additional processing [30, 36], 529 
whilst the box search task of Fox et al [38] required processing the reverse order 530 
presentation of previously learned stimuli. Reported visuospatial performance 531 
deficits may, therefore, reflect the extent of demand placed upon participants’ 532 
executive capacity by tasks of this type.  This would beg the question as to why 533 
three studies did show ecstasy related effects on tasks which do not seem to 534 
require more than the minimal additional processing characteristic of those listed 535 
14 
 
in Table 4. Overall ecstasy consumption would seem to be an unlikely 536 
explanation as Hanson and Luciana [43] report a relatively low level of 537 
consumption compared to studies listed in Table 4. Table 2 shows that Verkes et 538 
al [44], who did find visuospatial performance deficits on a basic block tapping 539 
procedure, also report a much shorter period since last ecstasy use  than studies 540 
with similar tasks listed in Table 4 [29, 40, 49]. However, this can only be a 541 
speculative explanation for differences in findings as differences in task demands 542 
make similar comparisons between studies problematic, and there was no formal 543 
analysis of the relationship between time since last ecstasy use and task 544 
performance in these studies. 545 
 546 
In summary, ecstasy related deficits have been reported on visuospatial tasks 547 
where potential confounds have been appropriately controlled. It is possible that 548 
such deficits may be related to the level of demand made upon executive 549 
capacity by the task in question. As there is no established measure of demand 550 
made by a task on executive resources, this is presumably an issue relevant to 551 
the field of substance use related executive effects as a whole.  552 
 553 
Discussion 554 
 555 
The evidence reviewed suggests that performance deficits in abstinent ecstasy 556 
users seem particularly evident in the updating of both verbal and visuospatial 557 
material, as well as other visuospatial tasks, especially where the demands on 558 
executive capacity are relatively high. However, shifting processes appear 559 
relatively immune to such deficits, and the evidence for their presence on 560 
inhibitory processes and access to LTM seems weak and ambiguous. From the 561 
range of brain regions which have been found to be associated with both verbal 562 
updating tasks and visuospatial memory tasks, respectively, both types of task 563 
have been associated with the dorsolateral prefrontal cortex (DLPFC), with 564 
increased activity being reported in the left hemisphere for verbal updating [50] 565 
and bilaterally for visuospatial tasks [51]. Increasing the workload of such tasks 566 
increased the activation of this and other implicated brain areas, rather than 567 
leading to the recruitment of new areas. Ecstasy related reductions in serotonin 568 
transporter (SERT) density have also been reported in the DLPFC [23], indicating 569 
a mechanism which may potentially underlie the relationship between ecstasy 570 
use and deficits in updating and visuospatial memory. However, the DLPFC has 571 
also been implicated in executive shifting [50] where there is little evidence of 572 
ecstasy related deficits, although parietal areas may be more important for this 573 
function. Significantly lower SERT densities in ecstasy users compared to 574 
controls, indicating impaired serotonergic functioning, were actually reported in 575 
12 brain regions using the radioligand [11C]McN5652 [23], including a number of 576 
those regions associated with updating, shifting, and inhibition. Where inhibition 577 
is concerned, the suggestion from this current review that the concept of 578 
executive inhibition may require further refinement before ecstasy related 579 
performance effects may be properly understood, reflects a similar conclusion by 580 
Colette et al. [50] in their review of the neural substrates of executive functioning. 581 
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They argue that a lack of homogeneity in this concept makes it difficult to 582 
interpret the role of brain regions reported to be associated with it.  583 
 584 
If there is a relationship between ecstasy use and performance deficits on tasks 585 
requiring verbal updating and visuospatial memory, respectively, why do not all 586 
studies using these tasks report such deficits? Our reading of the visuospatial 587 
studies which either did or did not report such deficits (see Tables 3 and 4 588 
respectively) suggests that future research should consider the extent of the 589 
executive workload posed by the tasks employed, in addition to the standard 590 
concerns of extent of ecstasy use and time since its last use. Furthermore, where 591 
verbal updating was concerned, it was noted that for the tasks which had failed to 592 
show ecstasy related deficits (reading span [12] and the keep track task [18]), 593 
variations to either the measures taken (e.g. recording the total correct responses 594 
for respective serial positions rather than span scores) or the procedure (e.g. 595 
keeping track of six categories rather than four), might have been more sensitive 596 
to the extent of executive demand. The prevailing concern of the studies 597 
reviewed was to establish whether or not ecstasy users performed worse on a 598 
task than nonusers, rather than the level of executive demand at which 599 
performance differences may appear. Greater use of the type of dual task 600 
procedure with a single task control condition used by Wareing et al. [45] might 601 
be one approach to this. 602 
 603 
One general limitation within this sample of reviewed studies was that only one 604 
[47] had a genuinely prospective design involving the recruitment of ecstasy 605 
naïve participants who were subsequently tested at a follow up point, by which 606 
time it was possible to compare task performance for those who had used 607 
ecstasy to those who had not. All of the other studies may be considered to have 608 
had cross-sectional, or quasi-experimental designs, by which pre-existing groups 609 
of ecstasy users and nonusers were recruited. Unfortunately, such designs make 610 
it impossible to rule out pre-existing differences between groups as a potential 611 
cause of performance differences. However, prospective studies in this field take 612 
years to complete, with there being the risk of insufficient ecstasy use within the 613 
sample by follow up for important research questions to be addressed. For 614 
example, in the case of Schilt et al. [47] the mean estimated consumption for 615 
users was 3.2 tablets after 3 years. True experimental studies would require the 616 
systematic administration of ecstasy / MDMA to participants randomly allocated 617 
to a user group, over a period running into years in order to mimic use in the 618 
community. Impairments to brain functioning and task performance would then 619 
be investigated in relation to randomly allocated control participants. Such a 620 
study would clearly be entirely unethical and unacceptable. Cross-sectional 621 
studies therefore become a necessary means of investigating ecstasy related 622 
executive deficits. In turn, this emphasises the importance of the replicability of 623 
findings and of the controls employed for potential confounds. 624 
 625 
All studies reviewed showed an awareness that ecstasy users have generally 626 
used other illegal drugs. Controlling for the potentially confounding effects of 627 
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cannabis is particularly important because of its potentially neurotoxic effects 628 
[52], and its high prevalence in the population. For example, in the United 629 
Kingdom it is estimated that over 9.5 million people have used cannabis at some 630 
time in their life [1]. Population statistics do not record cannabis use amongst 631 
ecstasy users, but within this review cannabis use was present in all ecstasy user 632 
groups except for Yip and Lee [34], although it was relatively rare in Halpern et al 633 
[30]. One statistical method used within the studies reviewed to control for the 634 
effect of other drugs, and also other potential confounds such as age and IQ, was 635 
ANCOVA. This method removes all the shared variability between a dependent 636 
variable (e.g. computation span) and a covariate (e.g. cannabis use) [20]. This 637 
has the conservative merit that any significant difference observed between 638 
ecstasy users and nonusers may be regarded as being free from the covariate’s 639 
influence. However, any variability shared by the covariate and the independent 640 
variable (e.g. between cannabis and ecstasy use) is also removed, so that the 641 
effects of any interaction between these drugs cannot be studied. This 642 
constitutes an important limitation of ANCOVA in this type of research. Its use, 643 
therefore, is a matter of choice with both benefits and costs which need to be 644 
understood. Where ANCOVA is used, its results should be qualified by reporting 645 
whether or not homogeneity of regression, in the form of a nonsignificant 646 
interaction between the covariate and the independent variable, was achieved 647 
[20]. Failure to achieve homogeneity of regression renders ANCOVA results 648 
invalid. Furthermore, testing for homogeneity of regression requires the covariate 649 
to be adequately represented in all groups constituting the independent variable, 650 
in order for the test itself to be meaningful.   651 
 652 
Many of the studies listed in Table 2 controlled for the effects of cannabis through 653 
group design. For example, participants were classified as users of both ecstasy 654 
and cannabis, users of cannabis but not ecstasy, or controls with no exposure to 655 
either drug [18, 32]. However, it would not be possible to design studies to control 656 
for all commonly misused drugs in this way, and the matching of participant 657 
groups on all potential confounds will always have a margin of error. A 658 
combination of matched groups and ANCOVA may, therefore, offer the best 659 
approach to control in future studies. One further technique for controlling for a 660 
potential covariate drug was to repeat a primary analysis whilst omitting 661 
participants with exposure to that drug. However, this is only possible if the 662 
reduced sample size does not diminish statistical power unacceptably. Bivariate 663 
correlation possibly offered the simplest means to highlight the relationship 664 
between specific drugs and task performance, although multiple analyses will 665 
require alpha levels to be adjusted appropriately [14]. 666 
 667 
Do ecstasy related deficits on laboratory tasks of executive functioning indicate 668 
that ecstasy is significantly harmful to its users in a practical sense? The 669 
laboratory based tasks employed by the studies reviewed here stand essentially 670 
as proxies for everyday behaviours from which it would be difficult to obtain 671 
precise measures in naturalistic settings, and which cannot easily be reproduced 672 
in a laboratory. It may therefore be useful to consider the findings of studies 673 
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which report impaired cognitive functioning of ecstasy users in everyday life [41, 674 
53] as providing an important additional perspective in evaluating the relevance 675 
of laboratory findings to assessments of ecstasy related harm in society. 676 
However, the self-report nature of data concerning ecstasy related cognitive 677 
impairments in everyday life may itself be seen as a limitation on the usability of 678 
such evidence, and confidentiality requirements would probably limit other forms 679 
of investigating the cognitive performance of ecstasy users in community 680 
settings.  681 
 682 
With minor exceptions, this review was limited to a restricted group of tasks with 683 
a demonstrated empirical link to the executive processes of updating, shifting, 684 
inhibition, access to LTM, or which drew upon certain aspects of visuospatial 685 
memory. Studies reporting ecstasy related deficits on other tasks believed to 686 
draw upon executive functioning were, therefore, not included [eg. 54]. Further 687 
empirical developments in mainstream cognitive psychology concerning the 688 
relationships of tasks to executive structure will benefit this area of research. It is 689 
recommended that future reporting of executive performance in users of ecstasy 690 
or any other drug should outline the relationship of the task administered to 691 
executive functioning. Where tasks generate multiple dependent variables clarity 692 
is needed in reporting and discussing these. These steps will enhance the clarity 693 
of evidence in this field. With regard to visuospatial memory, this review was 694 
limited to tasks requiring either recall or recognition of the spatial distribution of 695 
individual elements of a stimulus display. As any visual stimulus will have some 696 
spatial dimension to it would seem appropriate for a more extensive review of 697 
evidence concerning ecstasy use and visuospatial performance to be conducted. 698 
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Table 1 
 
Tasks empirically related to specific executive process [5, 7] 
________________________________________________________________ 
 
Updating 
________________________________________________________________ 
 
Letter memory 
Brooks spatial sequences 
Tone monitoring 
Computation span 
Reading span 
Consonant updating 
Operation span 
Keep track 
Random number generation 
________________________________________________________________ 
 
Shifting 
________________________________________________________________ 
 
Wisconsin card sorting 
Plus / minus 
Number / letter 
Local / global 
________________________________________________________________ 
 
Inhibition 
________________________________________________________________ 
 
Random letter generation 
Random number generation 
Stroop 
Tower of Hanoi / London 
Anti-saccade 
Stop signal 
________________________________________________________________ 
 
Access to long term memory 
_______________________________________________________________ 
 
Chicago word fluency 
Random letter generation 
________________________________________________________________ 
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Table 2 
 
Summary of studies identified in this review  
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Montgomery et al. 
(2007) [11]   (UK) 
 
Users: 21.68 yrs. 
(1.96) 
Controls: 21.11 yrs. 
(1.66) 
Predominantly student 
sample:103 ecstasy 
users, M = 19.35 
weeks (43.46) since 
last use: 103 controls 
with some polydrug 
use. 
349.97 
(464.41) 
Computation span & 
consonant updating 
(updating).  Chicago 
word fluency test 
(access to LTM) 
Age, IQ, and other 
drug use compared by 
t-tests. 
ANCOVA to control for 
sleepiness with 
executive measures.  
Deficits in users 
reported on all three 
executive tasks, which 
remained when 
sleepiness was 
controlled. 
Wareing et al. (2004) 
[12]       (UK) 
 
Current users: 21.69 
yrs. (2.57) 
Former users: 26.06 
yrs. (5.09) 
Controls: 23.39 yrs. 
(6.47) 
Student sample: 42 
current users, M = 
3.00 weeks (3.66) 
since last use: 17 
former users, M = 
111.66 weeks (87.98) 
since last use: 31 
controls with some 
polydrug use. 
Current users 552.99 
(681.49): former 
users 385.10 
(362.02). 
Reading span & 
computation span 
(updating). 
ANOVA & post hoc 
comparisons for 
intergroup IQ & age 
differences. ANCOVA 
to control for other 
drug use, age, & 
passive memory 
storage differences 
with executive 
measures. 
Both user groups 
showed deficits on 
both executive tasks 
which remained when 
age, other drug use, & 
passive memory 
storage differences 
were controlled. 
Fisk et al. (2004)  
[13]      (UK) 
 
Users: 21.52 yrs. 
(1.66) 
Controls: 21.37 yrs. 
(1.84) 
Predominantly student 
sample: 44 users, M = 
10.90 weeks (27.86) 
since last use: 59 
controls with some 
polydrug use. 
343.38 (376.94) Random letter 
generation (inhibition 
& LTM access). 
Computation span 
(updating) 
Age, education, IQ, & 
other drug use 
compared by t-tests. 
ANCOVA for other 
drug use with 
executive measures. 
Deficits in users on 
computation span with 
other drug use 
controlled. No 
intergroup differences 
on random letter 
generation. 
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Table 2 continued 
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Montgomery et al. 
(2005)   [14]    (UK) 
 
Users: 21.70 yrs. 
(1.66) 
Controls: 21.59 yrs. 
(1.88) 
Predominantly student 
samples. Study 1: 27 
users, M =  4.97 
weeks (7.27) since last 
use: 34 controls. 
Study 2: 51 users, M = 
22.15 weeks (40.71) 
since last use: 42 
controls. Both studies: 
controls had some 
polydrug use. 
Study1: 345.96 
(365.76) 
 
Study 2: 373.87 
(542.91) 
Study 1: consonant 
updating, computation 
span (updating). 
Chicago word fluency 
test (access to LTM).  
Study 2: Random 
letter generation  
(inhibition & LTM 
access). Plus / minus 
& number / letter 
(shifting) 
Both studies: t–tests 
for age, IQ, education, 
& sleepiness. 
Correlations examined 
between  performance 
& use of ecstasy & 
other drugs. 
Study 1: additional 
use of ANCOVA to 
control for IQ, 
sleepiness & gender. 
Users showed deficits 
on both updating 
tasks, but not on the 
inhibition or shifting 
tasks. Cannabis use 
was negatively 
correlated with 
updating performance 
& cocaine use with 
LTM access. 
Fisk & Montgomery 
(2009)    [15]     (UK) 
 
Heavy users: 22.86 
yrs. (2.38) 
Light users: 21.41 yrs. 
(2.05 
Controls: 20.71 yrs. 
(1.37) 
Predominantly student 
sample: 14 heavy 
users, M = 22 weeks 
since last use: 39 light 
users, M = 27 weeks 
since last use (no SDs 
given): 28 controls 
with some cannabis 
use. 
Heavy users 1,000.21 
(786.41): light users 
149.69 (96.91) 
Computation span, 
consonant updating 
(updating). Random 
letter generation 
(inhibition & LTM 
access). Spatial span 
& spatial updating 
(visuospatial 
memory).  
ANOVAs for age, 
education, IQ, passive 
memory storage 
differences, alcohol & 
tobacco use. 
ANCOVA to control for 
age, & alcohol, 
tobacco & cannabis 
use on performance.  
Users showed deficits 
on computation span 
& spatial updating, but 
not on random letter 
generation or spatial 
span. 
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Table 2 continued 
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Wareing et al. (2007) 
[16]      (UK) 
 
Current users: 21.72 
yrs. (2.00) 
Former users: 25.30 
yrs. (5.21) 
Controls: 22.58 yrs. 
(5.50) 
Sample origins 
unspecified: 29 current 
users, M = 1.86 weeks 
(1.50)  since last use : 
10 former users, M = 
124.60 weeks (94.05) 
since last use: 46 
controls with some 
polydrug use. 
Current users 536.00 
(515.73): Former 
users 525.90 
(410.02). 
Computation span 
(updating) 
ANOVAs for age 
education & IQ. 
ANCOVA controlled 
for information 
processing speed on 
computation span. 
Users deficits on 
updating remained 
when information 
processing speed was 
controlled. 
Montgomery & Fisk 
(2008)  [17]    (UK) 
 
Users: 21.77 yrs. 
(2.11) 
Controls: 20.73 yrs. 
(1.73) 
Predominantly student 
sample: 73 users, M = 
32.15 weeks (62.82) 
since last use: 73 
controls with some 
polydrug use. 
309.86 (486.25)  Consonant updating 
(updating). Spatial 
span, spatial updating 
(visuospatial 
memory). 
Age, education, IQ, 
passive memory 
storage differences, 
alcohol, tobacco & 
cannabis use 
compared by t-tests. 
Correlations between 
performance, 
cannabis & cocaine 
use examined 
Users showed deficits 
on consonant & 
spatial updating linked 
to serial presentation 
positions. No deficits 
shown on spatial 
span. 
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Table 2 continued 
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Dafters (2006)  
 [18]       (UK) 
 
Ecstasy/cannabis 
users: 23.24 yrs. (2.33) 
Cannabis controls: 
23.19 yrs. (1.15) 
Drug naïve controls: 
22.67 yrs. (2.56) 
Predominantly student 
sample: 18 ecstasy / 
cannabis users: 17 
cannabis using 
controls: 18 nearly 
drug naïve controls. 
All groups had some 
polydrug use. Time 
since last ecstasy use 
not reported. 
 522.33 (936.71) Keep track task 
(updating). Stroop 
task (inhibition, but 
with an additional 
improvised shifting 
measure which had 
not been empirically 
tested for its 
relationship to this 
function). 
Unspecified statistical 
analysis on measures 
of other drug use. 
Some of these 
measures were 
included as predictors 
in multiple regression. 
Users showed no 
deficits on updating or 
traditional Stroop 
measures. Deficits 
found on the 
improvised Stroop 
shifting measure.  
Wareing et al (2005)  
[19]       (UK) 
 
Current users: 21.81 
yrs. (2.52) 
Former users: 26.83 
(5.80) 
Controls: 22.39 yrs. 
(6.47) 
Predominantly student 
sample: 36 current 
users, M = 3.3 weeks 
since last use: 12 
former users, M = 
92.94 weeks (81.08) 
since last use: 31 
controls. All groups 
had some polydrug 
use. 
Current users: 591.33 
(718.44). Former 
users: 433.36 
(411.07). 
Simple visuospatial 
span, & visuospatial 
working memory span 
[i.e. with a related 
concurrent task] 
(visuospatial memory). 
Computation span 
(updating).  
ANOVAs for age, 
education, IQ, & other 
drug use. ANCOVAs 
on visuospatial 
working memory 
performance with age, 
simple spatial span, 
computation span, & 
other drug use as 
covariates. 
Users showed deficits 
in visuospatial 
working memory span 
& updating. No 
deficits were found in 
simple visuospatial 
span. 
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Table 2 continued 
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Morgan (1998) 
[22]      (UK) 
 
Study 1:  
Users: 20.94yrs. (1.88) 
Polydrug controls: 
20.25 yrs. (1.48) 
Drug naïve controls: 
21.87 yrs. (6.09) 
Study2:  
Users: 22.28 yrs. 
(2.48) 
Polydrug controls: 
23.00 yrs. (4.71) 
Drug naïve controls: 
21.74 (2.94) 
Samples of students 
or graduates. Study 1: 
16 users, M = 20.4 
days (33.6) since last 
use: 12 polydrug 
controls & 16 drug 
naïve controls. Study 
2: 25 users, M = 65.1 
days ( 85.7) since last 
use: 20 polydrug 
controls & 19 drug 
naïve controls. 
Study 1: 35.6 (17.5). 
Study 2: 49.6 (33.2) 
Study 1: Tower of 
London (inhibition). 
Spatial span 
(visuospatial memory). 
Study 2: Tower of 
London (inhibition). 
Both studies: Group 
design to control for 
polydrug use. 
MANOVA for age, 
gender ratio, 
education, height, 
weight, & pre-morbid 
IQ. Unspecified 
parametric analysis of 
other drug use.  
Study 1: no deficits 
shown by users 
regarding inhibition or 
spatial span. Study 2: 
no deficits shown by 
users regarding 
inhibition, but nondrug 
controls showed a 
trend for longer initial 
thinking times than 
both other groups. 
McCann et al (2007) 
[26]      (USA) 
 
Users: 22.08 yrs  
Controls: 25.69 yrs 
(SDs not given) 
Community sample: 
25 users, M = 3.09 (± 
6.92) months since 
last use: 23 controls 
with some polydrug 
use. 
112.3 exposures 
(range 30-324). 
Wisconsin card 
sorting task (shifting). 
Stroop task 
(inhibition). 
Age, education and IQ 
compared, but no 
details of statistical 
analysis given. 
Users showed no 
performance deficits. 
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Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Fox et al (2001)  
[27]      (UK) 
 
Problematic users: 
27.4 ± 4.5 yrs 
Nonproblematic users: 
26.2 ± 5.0 yrs 
Controls: 23.3 ± 6.5 
yrs 
Community sample: 
20 users with self-
reported ecstasy 
related problems, 7.8 
± 11.5 months since 
last use: 20 non-
problematic users, 
2.5 ± 5.4 months 
since last use: 20 
controls with some 
polydrug use. 
Self-reported problem 
users: 372.3 ± 663.3. 
Nonproblematic users: 
356.9 ± 339.8. 
Wisconsin card 
sorting task (shifting). 
Tower of London 
(inhibition). Spatial 
working memory 
(visuospatial 
memory). 
Nonparametric 
ANOVAs on other drug 
use. 
Both user groups 
showed impairments 
on inhibition and 
spatial working 
memory. No deficits 
were shown by users 
on shifting. 
Thomasius et al. 
(2003)  [28]       
(Germany) 
 
Current users: 24.50 ± 
4.00 yrs 
Former users: 24.13 ± 
4.21 yrs 
Polydrug controls: 
24.41 ± 4.55 yrs 
Drug naïve controls: 
23.13 ± 3.67 yrs 
Community sample: 
30 current users, 
21.60 ± 16.38 days 
for males & 24.73 ± 
16.32 days for 
females since last 
use: 31 former users, 
485.40 ± 533.09 days 
for males & 545.13 ± 
470.74 days for 
females since last 
use: 29 polydrug 
controls and 30 drug 
naïve controls. 
Current users: males, 
1,033.77 ± 1,702.44; 
females, 600.42 ± 
565.28. Former users: 
males, 987.31 ± 
824.50; females, 
533.80 ± 317.22. 
Wisconsin card 
sorting task (shifting). 
Group design to 
control for polydrug 
use. ANOVAs for age, 
education, IQ, 
psychopathology, & for 
alcohol, tobacco, & 
other drug use. 
Users showed no 
performance deficits, 
with both user groups 
making significantly 
fewer errors than 
polydrug controls. 
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Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated  
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Reneman et al (2006) 
[29]       (Holland) 
 
Moderate users: males 
25.6 ± 7.5 yrs., 
females 22.7 ± 2.8 
yrs. 
Heavy users: males 
27.1 ± 6.0 yrs., 
females 25.0 ± 4.1 
yrs. 
Former users: males 
26.4 ± 6.2 yrs., 
females 24.1 ± 4.7 
yrs. 
Polydrug controls: 
males 29.3 ± 6.9 yrs., 
females 23.3 ± 1.3 
yrs. 
Community sample: 
15 moderate users, 
4.3 ± 7.5 months for 
males & 2.7 ± 2.1 
months for females 
since last use: 23 
heavy current users, 
1.97 ± 2.67 months 
for males & 2.6 ± 2.1 
months for females 
since last use: 16 
former users, 37.1 ± 
25.4 months for males 
& 21.0 ± 10.1 months 
for females since last 
use: 15 polydrug 
controls. 
Moderate users: 29.5 
± 17.5 for males & 
27.3 ± 19.7 for 
females. Heavy 
current users: 831.8 ± 
733.0 for males & 
200.9 ± 171.2 for 
females. Former 
users: 126.9 ± 91.4 
for males & 409.3 ± 
868.7 for females. 
Stroop task 
(inhibition). Wisconsin 
card sorting task 
(shifting). Corsi block 
span tasks 
(visuospatial memory). 
ANOVA for education 
and other drug use. 
Unspecified analyses 
for age, gender, and 
pre-morbid IQ.  
Users showed no 
executive functioning 
deficits. 
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Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Halpern et al. (2004) 
[30]    (USA) 
 
Users: median = 20 
yrs., interquartile 
range 19, 20 yrs. 
Controls: median =22 
yrs., interquartile 
range 19, 25 yrs. 
 
Community sample: 
23 users, asked to 
abstain from ecstasy 
for at least > 10 days 
prior to testing: 16 
drug naïve controls. 
Subsamples: 11 heavy 
users, median 100 
episodes (range 60-
450), & 12 moderate 
users (range 22-50 
episodes). 
Wisconsin card sorting 
task (shifting).  WMS 
III spatial span 
(visuospatial memory) 
[Also the FAS task 
(access to LTM)]. 
Regression analyses 
controlling for age, 
gender, parental 
education, parental 
household income, 
family substance 
abuse history, & 
family  psychiatric 
history. 
Heavy users showed 
shifting deficits when 
age, gender, & family 
of origin variables 
were controlled, & 
visuospatial memory 
deficits when age & 
gender were 
controlled.  No deficits 
reported on access to 
LTM. 
Croft et al. (2001) 
[32]        (UK) 
 
Ecstasy/cannabis 
users: 25.7 yrs (4.7) 
Cannabis controls: 
26.6 yrs. (8.1) 
Controls: 23.5 yrs (6.8) 
Community sample: 11 
ecstasy/cannabis 
users: 18 cannabis 
using controls.. 
Abstinence > 48 hours 
requested from both 
drugs. Some polydrug 
use in both groups: 31 
near drug naïve 
controls. 
Ecstasy / cannabis 
users: 41.9 (49.3). A 
mean of 0.6 (1.3) was 
reported for the 
cannabis group. 
Stroop task 
(inhibition). [Also the 
FAS task (access to 
LTM)].  
Group design to 
control for cannabis 
use between user 
groups. ANOVAs for 
age, IQ, education 
levels, & gender, 
which were also 
included in some 
ANCOVAs. 
Equivocal findings 
reported regarding the 
relationship between 
ecstasy use and 
impaired inhibition 
indicated. No deficits 
reported on access to 
LTM. 
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Authors/study, 
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lifetime ecstasy use 
(Tablets unless 
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Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Morgan et al (2002) 
[33]        (UK)  
 
Current users: 23.4 ± 
3.2 yrs. 
Former users: 24.7 ± 
2.5 yrs. 
Polydrug controls: 22.1 
± 3.3 yrs 
Drug naïve controls: 
22.4 ± 4.1 yrs 
Community sample: 18 
current users, 5.1 ± 
3.9 weeks for males & 
3.0 ± 2.5 weeks for 
females since last use: 
15 former users, 110 ± 
58 weeks for males & 
113± 97 weeks for 
females since last use: 
16 polydrug  & 15 drug 
naïve controls. 
Current users: males, 
513 ± 470; females, 
93 ± 65. Former 
users: males, 336 ± 
248; females, 577 ± 
884.  
Stroop task 
(inhibition). [Also the 
FAS task (access to 
LTM)].  
Group design to 
control for polydrug 
use. ANOVA for age, 
gender ratio, 
education, height, 
weight, pre-morbid IQ, 
alcohol, tobacco, & 
other drug use.  
No deficits in users 
indicated for inhibition 
or access to LTM.  
Yip & Lee (2005) 
[34]        (Hong Kong) 
 
Users: 28.46 yrs. 
(5.71) 
Controls: 28.82 yrs. 
(5.78) 
 
 Community sample: 
100 users, M =  2.23 
months (0.51): 100 
implied drug naïve 
controls to match 
users. 
35.84 (13.21) Stroop task 
(inhibition) 
Strict exclusion criteria 
for alcohol, tobacco, & 
other drug use. 
ANOVA for age, 
education, non-verbal 
IQ & depression. 
Equivocal findings 
reported regarding the 
relationship between 
ecstasy use and 
impaired inhibition.  
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Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
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Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Dafters (2006) 
[35]       (UK) 
 
Users (> 50 tablets): 
23.24 yrs (2.33) 
Users (< 50 tablets): 
23.19 yrs. (1.15) 
Controls: 22.67 yrs 
(2.56) 
Predominantly student 
sample: 18 users of > 
50 tablets & cannabis: 
18 users of < 50 
tablets who had > 
exposures to 
cannabis: requested 
abstinence periods: 
ecstasy 5 days, 
cannabis 2 days: 18 
near drug naïve 
controls 
Users of > 50 tablets 
& cannabis: 522.33 
(936.71). Users of < 
50 tablets who had > 
exposures to 
cannabis: 4.00 (6.88).  
Stroop task 
(inhibition) 
Age differences 
reported but not 
tested. Group design 
controlled for 
cannabis. ANCOVA 
controlled for other 
drug use.  
Users of > 50 tablets 
& cannabis showed 
impaired inhibition 
related to negative 
priming, compared to 
the other groups. 
de Sola LLopis (2008) 
[36]   (Spain) 
 
Baseline: 
Users: 23.6 yrs. (3.5) 
Cannabis controls: 
22.0 yrs. (1.9) 
Drug naïve controls: 
22.0 yrs. (2.6) 
Community sample 
with follow-ups at 6, 
12 & 24 months. 
Baseline: 37 users 
with some polydrug 
use, 23 cannabis 
using controls with no 
polydrug use, & 34 
drug naïve controls 
(72 hour abstinence 
from illicit drug use 
requested). Some 
participants re-
classified at follow-up  
Baseline: 206 (228.3).  Tower of London 
(inhibition). Corsi 
block tapping task: 
backward sequence 
span (visuospatial 
memory). 
ANOVA or 2  for 
baseline age, gender, 
education, 
employment status, 
IQ. & drug use; 
repeated to compare  
the 24 months sample 
to drop outs: t-test for 
drug use changes 
between baseline & 
24 months. ANCOVA 
for gender & pre-
morbid IQ on 
executive tasks. 
Baseline: Heavy users 
(> 100 tablets) 
showed deficits on 
visuospatial memory, 
and ecstasy use 
correlated with 
planning times on the 
inhibition task. At 24 
months, the deficit in 
visuospatial 
performance 
persisted. 
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Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Wareing et al. (2000) 
[37] (UK) 
 
Current users: 22.20 
yrs. (2.20) 
Former users: 22.60 
yrs. (2.22) 
Controls: 22.60 yrs. 
(2.12) 
Community sample: 
10 current users M = 
8.20 days (5.75) since 
last use: 10 former 
users, M =  323.25 
days (130.05) since 
last use, (some 
polydrug use in both 
groups), 10 drug 
naïve controls.  
Current users: implied 
estimate of 1,349. 
Former users: implied 
estimate of 1,281. 
(SDs not calculable.)  
Random letter 
generation (inhibition 
& LTM access). 
ANOVA for self rated 
health, age , & 
education. ANCOVA 
for health, anxiety, 
arousal, and other 
drug use. 
Evidence of impaired 
inhibition for both 
users groups 
compared to controls. 
 
Fox et al (2002) 
[38]       (UK) 
 
Users: 27.3 ± 6.7 yrs. 
Controls: 27.5 ± 7.6 
yrs. 
Community sample: 
20 users with 
polydrug use, 
abstinent from illicit 
drug use for > 2 
weeks: 20 polydrug 
controls.  
172.0 ± 227.36 
(range 10 – 1,000). 
Spatial working 
memory, pattern & 
spatial recognition 
(visuospatial 
memory). Tower of 
London variant 
(inhibition). [Also the 
FAS task (access to 
LTM)]. 
Age, pre-morbid IQ, & 
other drug use 
compared by t-tests. 
ANCOVA for other 
drug use on task 
performance   
Users showed deficits 
on visuospatial 
memory except for 
spatial recognition, & 
access to LTM. No 
deficits found for 
inhibition. 
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Main findings for 
executive tasks 
identified in Table 1 
Semple et al. (1999) 
[39]        (UK) 
 
Users: 25.5 yrs. (4.4) 
Controls: 24.2 yrs (5.2) 
Community sample:  
40 users, M = 18.0 
days (8.0) since last 
use: 31 controls with 
some polydrug use. 
672 (647) Stroop task 
(inhibition). Spatial 
working memory & 
matching to sample 
task (both visuospatial 
memory). [Also the 
FAS test (access to 
LTM)]. 
Data reported for body 
size, demographic 
characteristics, pre-
morbid IQ, & other 
drug use, but not 
analysed for the full 
sample. 
No deficits in users on 
visuospatial memory, 
inhibition, or LTM 
access. Ecstasy use 
correlated with spatial 
working memory 
errors. 
Gouzoulis-Mayfrank et 
al. [40]    (Germany) 
 
Users: 23.25 yrs. 
(range 18-29) 
Cannabis controls: 
22.9 yrs. (range 18-31) 
Controls: 23.5 yrs 
(range 18-30) 
Community sample:28 
users, M = 41 days 
(71.1) since last use: 
28 cannabis using 
controls: 28 controls 
with no use of either 
drug. Regular users of 
any other illicit drug 
were excluded from 
all three groups. 
93.4 (119.9) Stroop task 
(inhibition). Corsi 
block tapping span 
test (visuospatial 
memory). [Also the 
FAS test (access to 
LTM)]. 
Gender, age and 
cannabis use reported, 
but only 2 analyses 
for education 
differences were 
reported. ANCOVAs 
on task performance 
with IQ as the 
covariate.   
No deficits reported 
for block tapping, 
inhibition, or LTM 
access.  
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Table 2 continued 
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated  
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Heffernan et al (2001) 
[41]         (UK) 
 
Users: 24.6 ± 5.89 
yrs. 
Controls: 26.1 ± 6.53 
yrs. 
Community sample: 
30 users with some 
cannabis & cocaine 
use: 37 cannabis 
using controls. 
Abstinence: cannabis 
> 3days, ecstasy > 1 
day. 
Not calculable Variant of Chicago 
word fluency test 
(access to LTM). 
ANOVAs for age. 
ANCOVAs for other 
drug use on task 
performance. 
Users showed deficits 
on access to LTM.  
Bhattachary & Powell 
(2001) [42]   (UK) 
 
Novice users: 23.6 ± 
3.0 yrs. 
Regular users: 23.8 ± 
3.4 yrs. 
Abstinent users: 24.6 
± 3.4 yrs. 
Controls: 22.1 ± 2.8 
yrs. 
Student & community 
sample: 18 novice 
current users, M = 
8.56 days (6.44) since 
last use: 26 regular 
current users, M = 
7.42 days (6.34) since 
last use: 16 abstinent 
users, M = 46.25 days 
(25.15) since last use 
& 20 drug naïve 
controls. All user 
groups had some 
polydrug use. 
Tablets/doses were 
rated on an ordinal 
frequency scale. 
Modal responses: 
novice current users, 
1 – 5: regular current 
users, > 51: former 
users, > 51.  
[FAS test (access to 
LTM)] 
2 for gender ratio. 
ANOVA for age & 
other drug use. 
Provision made for 
covariate analysis of 
other drug use if 
correlations with 
respective test 
performance were 
significant. 
Users showed deficits 
on access to LTM. 
Performance was 
negatively correlated 
with lifetime ecstasy 
consumption. 
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Table 2 continued 
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Hanson & Luciana 
(2004) [43]  (USA) 
 
Users: 21.3 yrs. (3.6) 
Controls: 20.7 yrs. 
(3.4) 
 
Student & community 
sample: 26 users, M = 
10.9 weeks (10.5) 
since last use: 26 
drug naïve controls. 
Users had some 
polydrug use. 
Episodes of use: M = 
64.9 (122.9).  
Spatial delayed 
response task 
(visuospatial 
memory). [Also the 
FAS task (access to 
LTM)]. 
2 for gender ratio, 
handedness 
distribution, ANOVA 
for age, depression, & 
IQ. Correlations with 
some measures of 
other drug use. 
Users performed 
better than controls on 
“no delay” spatial 
response trials, but 
were more impaired 
than controls in delay 
conditions. Users 
were also impaired on 
access to LTM. 
Verkes et al. (2001) 
[44]     (Holland) 
 
Heavy users: 21.7 yrs. 
(2.2) 
Moderate users: 22.1 
yrs. (2.3) 
Controls: 20.6 yrs. 
(2.2) 
 
Community sample: 
21 heavy users, M = 
9.0 days (7.5) since 
last use: 21 moderate 
users, M = 15.7 days 
(9.5) since last use: 20 
controls with some 
cannabis & 
amphetamine use. 
Heavy users: 741 
(678). Moderate 
users: 169 (252). 
Corsi block tapping 
span test (visuospatial 
memory). A variant of 
the Wisconsin card 
sorting task (called the 
classification task) 
was also used, but its 
results were not 
separately reported. 
Age, body weight, 
number of rave visits, 
education, ecstasy 
use, other drug use, & 
psychopathology were 
analysed by t-tests, 
with significant  results 
indicating covariates 
for ANCOVAs on task 
performance.  
Users showed deficits 
in visuospatial 
memory.  
39 
 
Table 2 continued 
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Wareing et al (2004)  
[45]        (UK) 
 
Current users: 21.92 
yrs. (2.80) 
Former users: 28.00 
yrs. (5.64) 
Controls: 25.22 yrs. 
(8.00) 
Predominantly student 
sample: 25 current 
users, M = 3.4 weeks 
(2.87) since last use: 
10 former users, M  = 
107.93 weeks (80.80) 
since last use: 18 
controls. All groups 
had some polydrug 
use. 
Current users: 655.58 
(805.50). Former 
users: 469.20 
(414.96). 
Simple visuospatial 
span, & visuospatial 
working memory span 
[i.e. with a related 
concurrent task], with 
additional random 
letter generation as a 
dual task (visuospatial 
memory & inhibition). 
ANCOVAs on 
visuospatial working 
memory performance 
using age, education, 
IQ, and other drug use 
as covariates.  
Users showed deficits 
in visuospatial 
working memory 
span, but not in 
simple visuospatial 
span.  
McCann et al (1999) 
[46]       (USA) 
 
Users: 26.23 ± 1.99 
yrs. 
Controls: 30.35 ± 1.98 
yrs. 
Community sample 
(users were self-
referred inpatients): 
22 users, 13.91 ± 
6.54 weeks since last 
use: 23 polydrug 
controls.  
215 ± 33 exposures Matching to sample 
task (visuospatial 
memory). 
Data for age, gender, 
education, & other 
drug use are reported 
but not analysed.  
Users showed no 
impairments on 
visuospatial memory. 
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Table 2 continued 
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated 
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Schilt et al (2007)  
[47]     (Holland) 
 
Baseline: Users: 21.8 
yrs. (3.1) 
Controls: 21.5 yrs. 
(2.1) 
 
Prospective 
community sample 
with zero baseline 
ecstasy use (N = 188), 
and 3 year follow up. 
At follow up: 58 users, 
M = 11.8 weeks (12.0) 
since last use: 60 
controls with some 
cannabis & cocaine 
use. 
At follow-up: 3.2 (5.2) Judgement of line 
orientation from 
memory (visuospatial 
memory) 
Mann-Whitney tests 
for other drug use & 
level of education at 
baseline & follow up, 
& t-tests for age & 
verbal IQ. MANCOVA 
for ecstasy, other drug 
use, verbal IQ & age, 
on baseline to follow 
up performance 
comparisons. 
Users showed no 
impairments on 
visuospatial memory. 
 
Schilt et al (2007) 
[48]     (Holland) 
 
Whole sample: 23.5 
yrs (3.9) 
Group statistics not 
given. 
 
Community sample: 
31 designated users 
with consumption > 10 
tablets: 36 designated 
‘nonusers’ with 
consumption < 10 
tablets. M = 8.7 weeks 
(9.9) since last use. 
Other drug use levels 
within groups not 
given. 
Designated users: 
327 (364) 
Judgement of line 
orientation from 
memory (visuospatial 
memory) 
Unspecified analysis 
of ages between the 
groups. Hierarchical 
regression to control 
for other drug use, 
age, & IQ on task 
performance. 
Users showed no 
impairments on 
visuospatial memory. 
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Table 2 continued 
Authors/study, 
(country), & 
participants’ mean 
(SD) ages if given 
Sample details: 
Means (M) with (SDs) 
in brackets in most 
cases 
Mean (SD) estimated  
lifetime ecstasy use 
(Tablets unless 
stated) 
Executive tasks used 
& related  functions 
identified in Table 1 
Statistical controls for 
potential intergroup 
confounds 
Main findings for 
executive tasks 
identified in Table 1 
Rodgers (2000) 
[49]       (UK) 
 
Users: 31.42 yrs. 
(4.17) 
Cannabis controls: 
30.25 yrs. (6.25) 
Drug naïve controls: 
32.08 yrs (4.08) 
Community sample: 
15 users with some 
polydrug use, ecstasy 
free > 2 months prior 
to testing: 15 
cannabis using 
controls with no 
polydrug use: 15 drug 
naïve controls. 
20 exposures Visual memory span 
(visuospatial memory) 
Group design to 
control for cannabis 
use, but no statistical 
comparisons on 
demographic or drug 
related variables. 
Users showed no 
impairments on 
visuospatial memory. 
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Table 3 
 
Studies reporting either an ecstasy related performance deficit on or a 
relationship between ecstasy use and performance on visuospatial memory tasks 
________________________________________________________________ 
 
 Study       Task details 
________________________________________________________________ 
 
Fisk & Montgomery [15] Updating and recall of sequentially highlighted 
computerised grid cells 
 
Montgomery & Fisk [17] Updating and recall of sequentially highlighted 
computerized grids.  
 
Wareing et al [19] Single task procedure: Computerised grid 
processing for an auxiliary task, and grid recall 
 
Fox et al [27] Recall of sequentially illuminated windows in a 
computerised ‘house’ image 
 
Halpern et al. [30]   Backward and total spatial span – Wechsler  
                                                      Memory Scale (WMS-III) 
 
De Sola LLopis et al. [36] Corsi block tapping: backwards spatial 
sequence recall. 
 
Fox et al [38]    Computerised box search requiring the  
      development of a search strategy 
 
Semple et al. [39]   Computerised box search requiring the  
      development of a search strategy 
 
Hanson & Luciana [43] Computerised spatial location recall 
 
Verkes et al [44]   Corsi block tapping – spatial sequence recall 
 
Wareing et al [45] Dual task procedure: Computerised grid 
processing for an auxiliary task and grid recall, 
plus concurrent random letter generation 
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Table 4 
 
Studies reporting no ecstasy related deficits on or relationships between ecstasy 
use and visuospatial memory task performance 
________________________________________________________________ 
 
 Study       Task details 
________________________________________________________________ 
 
Fisk & Montgomery [15]  Computerised grid recall only 
 
Wareing et al. [19, 45]  Computerised grid recall only 
 
Morgan [22]    Computerised block tapping 
 
Reneman et al. [29]   Corsi block tapping – spatial sequence recall 
 
Fox et al. [39]   Computerised spatial location recognition 
 
Semple et al. [39]   Computerised matrix matching 
 
Gouzoulis-Mayfrank et al. [40] Corsi block tapping – spatial sequence recall 
 
McCann et al. [46]   Computerised matrix matching 
 
Schilt et al. [47, 48]   Judgement of line orientation from memory 
 
Rodgers [49]    Visual memory span: block tapping 
 
 
 
 
 
 
